About MDisrupt
MDisrupt is a company based in San Jose (United States) founded in 2019 by Jill Hagenkord and Ruby Gadelrab. MDisrupt has raised $10 million across 3 funding rounds from investors including American Heart Association, BREN and The Venture Collective. MDisrupt operates in a competitive market with competitors including Definitive Healthcare, Axtria, Doceree, IMS Health and Prospection, among others.
- Headquarter San Jose, United States
- Founders Jill Hagenkord, Ruby Gadelrab
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mdisrupt Holdings, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Seed
Oct 15, 2024
-
Investors
American Heart Association
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of MDisrupt
Unlock access to complete
Funding Insights of MDisrupt
MDisrupt has successfully raised a total of $10M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MDisrupt
MDisrupt has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include American Heart Association, BREN and The Venture Collective.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Foundation fund specialising in cardiovascular conditions
|
Locked | Locked | Locked | |
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
Healthcare transformation is supported through investments by Capita3.
|
Locked | Locked | Locked |
Investor details for MDisrupt
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MDisrupt
Investment portfolio details for MDisrupt
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MDisrupt
Detailed financials for MDisrupt
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mdisrupt Comparisons
Peer comparison for MDisrupt
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MDisrupt
MDisrupt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Definitive Healthcare, Axtria, Doceree, IMS Health and Prospection, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers market intelligence and data analytics for healthcare providers and physicians
|
|
| Locked | Locked | Locked |
Data analytics and AI solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of pharmaceutical advertising and healthcare marketing platform
|
|
| Locked | Locked | Locked |
SaaS and AI-based market intelligence is provided for healthcare companies.
|
|
| Locked | Locked | Locked |
AI and cloud-based analytics for healthcare providers are offered.
|
Detailed competitors of MDisrupt
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mdisrupt
Complete news archive for MDisrupt
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MDisrupt
MDisrupt was founded in 2019 and raised its 1st funding round 3 years after it was founded.
MDisrupt is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Ruby Gadelrab is the current CEO of MDisrupt. They have also founded this company.
MDisrupt is a funded company, having raised a total of $10M across 3 funding rounds to date.
MDisrupt was founded in 2019 and is based in San Jose, United States. In the healthcare technology sector, software is offered to support medical diligence processes. Products, data, and claims are analyzed through the platform. Scores are generated based on defined clinical parameters. Detailed reports are compiled by integrating these analyses and scores, aiding in informed decision-making for stakeholders.
MDisrupt's top competitors include Axtria, Doceree and Definitive Healthcare.
MDisrupt has 15 investors. Key investors include American Heart Association, BREN, The Venture Collective, Capita3, and Geek Ventures.